RHYTHM AI announces new STAR Apollo Mapping System to feature at Rhythm Interventions Online (RIO) Congress
RHYTHM AI announces new STAR Apollo Mapping System to feature at Rhythm Interventions Online (RIO) Congress STAR Apollo Mapping System to feature with ‘Live in the Box’ case presentation This novel US FDA 510k cleared technology uses advanced AI to identify regions of the heart, specific to each patient, that are potential drivers of Atrial Fibrillation London, 29th November 2023: RHYTHM AI Ltd, a UK company focused on optimising Atrial Fibrillation (AF) procedures, today announces that its lead product STAR Apollo Mapping System will feature in a live ‘in the box’ case presentation at the Rhythm Interventions Online (RIO) Congress on 29th November. The case was performed and will be presented by Dr Devi G Nair MD, Director of Cardiac Electrophysiology at St. Bernards Medical Center, Jonesboro, Arkansas. The STAR Apollo Mapping system is US FDA 510k cleared technology that collects data from the standard 3D Cardiac Mapping system and uses advanced AI driven algorithms based on fundamental electrophysiological principles to show repeating patterns within the arrythmia and identify regions of the heart that are potential drivers of AF. This allows the physician to create a customised treatment plan for each specific patient. The case demonstration will feature a patient with recurrent Persistent AF who has previously had an ablation procedure and was referred to Dr Nair for further treatment. Dr Devi Nair MD commented: “In the evolving landscape of available atrial fibrillation ablation technologies I believe the STAR Apollo Mapping System is a valuable addition in the treatment of patients with persistent AF, providing a precise guide to early sites of activation and the predominant wavefront direction.” Simon Hubbert, Chief Executive of RHYTHM AI Ltd, commented: "We are very encouraged by Dr Nair’s feedback, and that of other early users, as we start to roll out a limited US launch of our STAR Apollo Mapping system following FDA 510k clearance”
Editor Details
-
Name:
- pharmiweb